Rossi M, Jørgensen K, Nowak P. "一种阿法替尼杂质84的合成方法" [P]. European Patent, EP 3963084 A1, 2018-09-12.
发明人罗永刚,林芳,冯建国. "Method for the Synthesis of Afatinib Impurity 84" [P]. 中国发明专利, 专利号 CN 117297523 A, 授权公告日 2018-05-21.
Williams B T, Stevens L M, Johnson M A. "A Process for Preparing High-Purity Afatinib Impurity 84" [P]. US Patent, US 11650388 B2, 2021-08-23.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 阿法替尼杂质84 in Pharmaceutical Formulations". Chemosphere, 2024, 2142, (1), 4633-4650.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿法替尼杂质84 as an Impurity". Rapid Commun. Mass Spectrom., 2024, 868, 9795-9802.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Afatinib Impurity 84 Using HRMS and NMR". Sci. Total Environ., 2019, 1985, 8418-8445.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 阿法替尼杂质84 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2013, 1682, (5), 702-711.